SCHEMBL14410312

SCHEMBL14410312

CC12CCC3c4ccc(OSOOO)cc4CCC3C1CCC2=O

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B1 P14061 3/20 0.70
LMNA P02545 2/20 0.70
MAPT P10636 2/20 0.70
RECQL P46063 1/20 0.70
SMN1; SMN2 Q16637 1/20 0.70
STS P08842 10/20 0.68
ABCC4 O15439 1/20 0.68
CYP2C9 P11712 1/20 0.68
ABCC1 P33527 1/20 0.68
SLCO1B1 Q9Y6L6 1/20 0.68
CA1 P00915 3/20 0.66
CA2 P00918 3/20 0.66
CA9 Q16790 3/20 0.66
KDM4E B2RXH2 2/20 0.66
ESR1 P03372 2/20 0.66
ESR2 Q92731 2/20 0.66
CA4 P22748 1/20 0.66
CA6 P23280 1/20 0.66
ALDH1A1 P00352 1/20 0.65
CYP3A4 P08684 3/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10116706 1.00 HSD17B1 (0.70) HSD17B1LMNAMAPTRECQLSMN1; SMN2
SCHEMBL10116722 0.90 LMNA (0.70) HSD17B1LMNAMAPTRECQLSMN1; SMN2
SCHEMBL194231 0.86 HSD17B1 (0.81) HSD17B1LMNAMAPTRECQLSMN1; SMN2
SCHEMBL20689748 0.85 HSD17B1 (0.76) HSD17B1LMNAMAPTRECQLSMN1; SMN2
SCHEMBL22475387 0.85 HSD17B1 (0.76) HSD17B1LMNAMAPTRECQLSMN1; SMN2
SCHEMBL15326183 0.85 HSD17B1 (0.76) HSD17B1LMNAMAPTRECQLSMN1; SMN2
SCHEMBL6684274 0.84 HSD17B1 (0.84) HSD17B1LMNAMAPTRECQLSMN1; SMN2
SCHEMBL4570835 0.83 HSD17B1 (1.00) HSD17B1LMNAMAPTRECQLSMN1; SMN2
SCHEMBL959954 0.83 HSD17B1 (1.00) HSD17B1LMNAMAPTRECQLSMN1; SMN2
SCHEMBL18658723 0.83 HSD17B1 (1.00) HSD17B1LMNAMAPTRECQLSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070225512-A1 SYNTHESIS OF A MIXTURE OF SULFATED ESTROGENS USING A SULFUR TRIOXIDE COMPLEX LEONARD THOMAS W 2007-09-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070225512-A1 SYNTHESIS OF A MIXTURE OF SULFATED ESTROGENS USING A SULFUR TRIOXIDE COMPLEX HSD17B11, STS, SULT1E1 HSD17B1 21/4885LMNA 4490/4885MAPT 3779/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.